Diurnal cortisol and obesity in adolescents with and without Down syndrome by Pitchford, E. A. et al.
Diurnal cortisol and obesity in adolescents with and
without Down syndrome
E. A. Pitchford,1,2 R. E. Hasson,1,6 J. E. Hornyak,3 J. C. Lumeng,4,5,6 K. E. Peterson6,5
& D. A. Ulrich1
1 School of Kinesiology, University of Michigan, Ann Arbor, MI, USA
2 Department of Kinesiology, Iowa State University, Ames, IA, USA
3 Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA
4 Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA
5 Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USA
6 School of Public Health, University of Michigan, Ann Arbor, MI, USA
Abstract
Background The prevalence of obesity in adolescents
with Down syndrome (DS) far exceeds that in the
general population. Cortisol, an adrenal hormone,
can be obesogenic when dysregulated. However, the
diurnal patterns of this hormone have not been
examined among individuals with DS. Variations in
adiposity may also mediate cortisol regulation. This
study sought to examine diurnal cortisol patterns in
adolescents with DS as well as associations between
cortisol function and obesity.
Method A total of 32 adolescents, including 16 with
DS and 16 controls with typical development (TD) of
similar sex, age and Tanner pubertal stage (P > 0.05),
participated in this preliminary study. Participants
completed a dual-energy X-ray absorptiometry scan
to measure body composition and collected saliva
samples for cortisol measurements in the morning,
afternoon and night. Linear mixed models with
random intercepts and repeated measures were used
to examine the daily trajectory of log-transformed
cortisol concentrations between adolescents with and
without DS. A second model examined the
interaction between DS and presence of elevated
body fatness.
Results Adolescents with DS had higher morning
cortisol concentrations (intercept = 0.37 μg/dL), but
this was not significantly different than in TD
(0.35 μg/dL, P = 0.16). Cortisol significantly declined
across hours (b = 0.026 μg/dL/h, P < 0.001), but
this decline also did not differ from that observed in
TD (b = 0.024 μg/dL/h, P = 0.43). While cortisol
levels were slightly higher among adolescents with
elevated body fatness, this difference was not
statistically significant (P > 0.05; d = 0.30).
Conclusions This study is the first to examine diurnal
cortisol in DS but is limited in sample size. These
preliminary findings suggest that diurnal cortisol
patterns are not significantly different between
adolescents with DS and TD and that cortisol levels
are not associated with adiposity in this population.
Despite these non-significant differences, youth with
DS continue to be an ‘at-risk’ population for
paediatric obesity in need of clinical intervention.
Keywords adiposity, cortisol, Down syndrome,
endocrine, obesity, puberty
Introduction
Down syndrome is the most common genetic form of
intellectual disability, with a prevalence estimated at
14.47 per 10 000 live births (Parker et al. 2010). While
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the life expectancy of persons with Down syndrome
has increased substantially because of advancements
in health care, morbidity and early mortality remain
significantly higher than in the general population
(Glasson et al. 2014; Torr et al. 2010). Addressing
secondary health conditions is critical to improving
long-term health outcomes in this population.
Obesity is highly prevalent among persons with Down
syndrome. Approximately 55% of youth with Down
syndrome are overweight or obese (Rimmer et al.
2010) compared with 31% of youth in the general
population (Ogden et al. 2014). Adolescents with
Down syndrome have also been shown to exhibit
greater body fat percentages, more total fat mass, less
total lean mass and greater abdominal obesity than
the general population (Bandini et al. 2012; Gonzalez-
Aguero et al. 2011; Loveday et al. 2012; Pitchford et al.
2018).
The foundation for obesity is energy imbalance
between caloric intake and energy expenditure, but
many factors contribute to the development of excess
fat mass. A recent systematic review from Bertapelli et
al. (2016) provided a thorough overview of potential
determinants of obesity in children and adolescents
with Down syndrome, including physical activity
levels, dietary intake and feeding behaviours, resting
energy expenditure and thyroid function. Additional
physiological functions, such as leptin (Magge et al.
2008), may also play mechanistic roles in obesity for
this population but are in need of further
investigation.
The hypothalamic–pituitary–adrenal (HPA) axis
regulates a variety of endocrine processes, including
energy storage and energy expenditure (De Vriendt
et al. 2009; Rodriguez et al. 2015; Adam & Epel
2007; Bjorntorp 2001). Activation of the HPA axis
increases cortisol secretion from the adrenal glands
(Bjorntorp 2001; Adam & Epel 2007; De Vriendt et
al. 2009; Bjorntorp 1996). Cortisol can affect
circulating energy substrate levels in the blood by
increasing gluconeogenesis and lipolysis (Adam &
Epel 2007; Bjorntorp 2001; Bjorntorp & Rosmond
2000). Visceral adipose tissue is especially sensitive
to cortisol because of an increased density of
glucocorticoid receptors and regulating enzymes.
Glucocorticoids, including cortisol, enhance the
size and number of fat cells and may play a role in
the redistribution of adiposity into the visceral
depot (Bjorntorp 2001; Adam & Epel 2007;
Bjorntorp 1996; De Vriendt et al. 2009; Rodriguez
et al. 2015).
Hypothalamic–pituitary–adrenal axis hormones,
including cortisol, are characterised by a circadian
diurnal pattern with high levels in the morning and
decay of output throughout the day (Pasquali et al.
2006). Multiple types of cortisol dysregulation can
influence the development of obesity. First, higher
cortisol levels upon waking are commonly associated
with greater body mass index (BMI) (Bjorntorp 2001;
Bjorntorp 1996; De Vriendt et al. 2009). Second,
blunted cortisol reactivity and circadian rhythms
throughout the day are associated with greater
abdominal obesity (Bjorntorp 2001; Adam & Epel
2007; De Vriendt et al. 2009; Bjorntorp 1996), as
these likely result in greater total cortisol output
across the day. Third, cortisol is also associated with
greater insulin and leptin resistance, increased
neuropeptide Y release and multiple markers of
metabolic syndrome, thus promoting metabolic
dysregulation and increased food intake (Bjorntorp
2001; Adam & Epel 2007; Nieuwenhuizen & Rutters
2008; Pasquali et al. 2006).
Although most research has been conducted in
adults, multiple studies have identified associations
suggesting that cortisol levels are higher in youth
with greater adiposity (Reinehr et al. 2014; Misra et
al. 2008; Guzzetti et al. 2014; Weigensberg et al.
2008, Barat et al. 2007; Veldhorst et al. 2014; Hill et
al. 2011; Rosmalen et al. 2005). It should be noted
that these associations are highly variable and many
significant findings are limited to specific subgroups
within studies (e.g. obese girls) (Hill et al. 2011;
Rosmalen et al. 2005). However, multiple large
studies report the opposite direction of association
with lower cortisol levels significantly associated with
higher adiposity (Ruttle et al. 2013; Ondrak et al.
2011; Shirtcliff et al. 2012; Kjölhede et al. 2014).
Independent of BMI or adiposity, cortisol has strong
positive associations with insulin resistance and
other markers of metabolic syndrome (Rubin et al.
2005; Adam et al. 2010; Prodam et al. 2013; Reinehr
et al. 2014; Misra et al. 2008; Guzzetti et al. 2014;
Weigensberg et al. 2008; Barat et al. 2007),
indicating further relevance of this hormone to
overall physical health.
There is limited research on cortisol function in
persons with Down syndrome (Murdoch et al. 1979;
Arnell et al. 1996; Hestnes et al. 1991; Anneren et al.
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1; Bricout et al. 2008), but the most recent evidence
suggests that persons with Down syndrome may
exhibit characteristics of cortisol dysfunction that
could promote obesity (Bricout et al. 2008).
Significantly lower cortisol levels during rest and a
blunted cortisol response to exercise were observed in
young adult men with Down syndrome compared
with controls (Bricout et al. 2008). However, other
studies have reported normal cortisol values or
differences that did not reach statistical significance
(Anneren et al. 1986; Hestnes et al. 1991; Arnell et al.
1996; Murdoch et al. 1979). To our knowledge, no
studies have tracked changes in cortisol across the day
in this population, despite the known diurnal
fluctuation of cortisol (Pasquali et al. 2006).
Describing this diurnal pattern among individuals
with Down syndrome is a first step in examining the
association between this hormone and health
outcomes. Furthermore, cortisol function has not
been examined within the scope of obesity in Down
syndrome. Given the influence of cortisol on body fat
(Bjorntorp & Rosmond 2000), the high rates of
obesity and greater fat mass observed in adolescents
with Down syndrome (Gonzalez-Aguero et al. 2011;
Rimmer et al. 2010) may be associated with
dysregulation of cortisol.
The purpose of this study was to provide a
preliminary investigation of the clinical differences in
diurnal cortisol patterns in adolescents with Down
syndrome and with typical development.
Furthermore, this study sought to examine the
independent and interactive associations between
Down syndrome and elevated body fatness on diurnal
cortisol function. These associations may be clinically
relevant to understanding the potential contributions




Participants were adolescents with Down syndrome
or typical development between 12 and 18 years old
and Tanner stages III to V (Marshall & Tanner 1969;
Marshall & Tanner 1970). Exclusion criteria to
participation included (1) documented history of
hormonal insufficiency (e.g. hypothyroid); (2) use of
medication that could alter metabolic functions (e.g.
prednisone, central nervous system stimulants,
growth hormone and thyroid hormone); (3) co-
morbid disease (e.g. diabetes); and/or (4) dual
disability diagnosis (e.g. autism). Adolescents with
and without Down syndrome had similar group
averages for sex ratio, age and Tanner pubertal stage
(P > 0.05). Matching groups on cognitive function or
other developmental indices was considered but
would have resulted in a prepubertal control group
with different hormone profiles. Participants were
recruited through Down syndrome parent support
groups in Michigan and northern Ohio, family
referrals and from previous study engagement with
the Center on Physical Activity and Health in
Pediatric Disabilities. The study was approved by the




Tanner’s stages of pubertal development were used to
describe the maturational state of participants
(Marshall & Tanner 1969; Marshall & Tanner 1970).
Pubertal stage was estimated via parental report using
schematic line drawings (Morris & Udry 1980).
Strong correlations have been shown in Tanner
assessment between line drawings and physical exams
(Morris & Udry 1980). Parental reports can provide
an acceptable estimate of pubertal stage (Coleman &
Coleman 2002) and are less invasive and stressful
than traditional physical assessment. Minimising
stress, which directly influences cortisol levels
(Bjorntorp 2001; De Vriendt et al. 2009), was critical
to not skew study outcomes. Tanner stage was
calculated as the average of reported stages for each
participant (i.e. women: breast and pubic hair
development; men: genital and pubic hair
development). All participants were adolescents in
Tanner stages III to V.
Anthropometry
All anthropometric measurements were conducted
according to established guidelines (Lohman et al.
1988). Height was measured to the nearest 0.1 cm and
weight was measured to nearest 0.01 kg to calculate
BMI (kg/m2) and BMI percentile from the U.S.
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Centers for Disease Control growth reference
(Kuczmarski et al. 2000).
Dual-energy X-ray absorptiometry
Each participant completed one dual-energy X-ray
absorptiometry (DXA) scan [Lunar Prodigy Advance
(DPX-IQ 240) densitometer; GE Healthcare,
Madison, WI]. DXA scans provided a three-
component (fat mass, lean body mass and bone mass)
analysis of body composition. Participants wore light
clothing and were positioned in a supine position with
hands by the sides in a neutral position. A warm
blanket was used to assist the participant with
maintaining position during the scan, if needed.
Paediatric software (enCore 14.0; GE Healthcare)
estimated body fat percentage. Obesity was classified
based on age-specific and sex-specific cut-points for
elevated total body fat percentage (Freedman et al.
2009).
Saliva sampling
To measure diurnal patterns in cortisol, each
participant provided three saliva samples per day for
three consecutive days (nine samples total). Salivary
cortisol is highly correlated with free serum cortisol
(Dorn et al. 2007) and is the most common approach
to naturalistic cortisol measurement. The three daily
samples were scheduled respective to the participant’s
waking times on that day. Sampling times included
(1) immediately after waking; (2) an afternoon
measurement occuring when the participant returned
home from school or daily activity (approximately
3:00 to 5:00 pm); and (3) immediately prior to
bedtime. These time points were consistent with
methodology for diurnal salivary cortisol
measurement (Hoyt et al. 2014; Keiver et al. 2015;
Ruttle et al. 2013; Shirtcliff et al. 2012). Participants
were instructed not to eat, drink or brush their teeth
in the 30 min before each sample. The participant’s
wake time, bedtime and saliva sample collection times
were reported on a brief questionnaire.
Saliva was collected with an oral swab (Salimetrics,
State College, PA). Participants placed the swab
underneath the tongue to absorb saliva for 3 to 5 min
while seated. The saturated swab was then stored in
an individually numbered polypropylene vial and
frozen for storage. Cortisol concentration (μg/dL) was
measured using enzyme-linked immunosorbent assay
techniques with the Expanded High Range Sensitivity
Salivary Cortisol Enzyme Immunoassay Kit
(Salimetrics). The assay had a lower limit of
sensitivity of 0.007 μg/dL (Shirtcliff et al. 2001) and
acceptable inter-assay (5.53%) and intra-assay
(5.14%) coefficients of variation (Reed et al. 2002).
Statistical analysis
All statistical analyses were conducted using SPSS
22.0 (IBM Corp., Armonk, NY) with an a priori α of
0.05. Characteristics of the sample were described
using descriptive statistics, Pearson’s chi-square (χ2)
tests for dichotomous data and independent t-tests for
continuous data with Cohen’s d effect sizes.
To be included in the analyses, a participant
needed to have at least five valid cortisol
measurements across two or more days. A total of 286
cortisol data points from the 32 participants were
included in the analyses, with 11 (3.7%) data points
missing. The other measures (i.e. anthropometry,
DXA and Tanner staging) did not have missing data.
Cortisol data were not normally distributed; thus, all
analyses were performed on logarithmically
transformed cortisol values. However, figures were
designed with raw cortisol values to aid in
interpretation.
Linear mixed model (LMM) techniques were
employed to examine associations between Down
syndrome and adiposity on the diurnal pattern of
cortisol. LMM allows for random parameters
estimates, is not limited by non-independent
observations (e.g. repeated measures) and does not
require an equal number of data points, thus
accommodating missing values. All models include
random intercepts to estimate cortisol concentration
at wakening and repeated time parameters to account
for decreases in cortisol across the day. Hours since
waking was included as a covariate in all models. Sex,
age and Tanner pubertal stage were all examined as
covariates but were not statistically significant in any
model and were removed in favour of parsimony and
maximising statistical power. Each model examined
specific associations with log-transformed diurnal
cortisol pattern: model 1 examined the presence of
Down syndrome on cortisol and model 2 examined
the interaction between Down syndrome and
adiposity on cortisol as well as the independent
presence of elevated fat mass on cortisol in
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adolescents with Down syndrome (model 2b) and
typical development (model 2c).
Results
The final sample included participants with valid
cortisol data and all covariates (n = 32). Groups had
similar compositions based on group averages of age,
sex and Tanner pubertal stage (P > 0.05; Table 1).
Large differences were observed across all measures
of body composition (Table 2), except for weight
(P = 0.99, d < 0.01). Adolescents with Down
syndrome had significantly greater BMI (P = 0.001,
d = 1.12), BMI percentiles (P < 0.001, d = 1.35) and
body fat percentage (P = 0.04, d = 0.70). The
proportion of participants classified as overweight
(Kuczmarski et al. 2000) and with an elevated body fat
percentage (Freedman et al. 2009) were both
significantly greater among adolescents with Down
syndrome than with typical development (P < 0.01).
Cortisol followed the expected diurnal pattern with
high levels in the morning and low levels at night.
Model 1 (Table 3) showed a significant linear
decrease in log-cortisol across hours of the day
(b = 0.12, SE = 0.02, P < 0.001). This corresponds
to an average decrease in cortisol concentration of
0.026 μg/dL per hour. Adolescents with Down
syndrome exhibited higher morning cortisol
concentration (0.37 μg/dL) than did adolescents with
typical development (0.35 μg/dL). However, there
were no significant differences between groups in log-
cortisol at the intercept (b = 0.23, SE = 0.16,
Table 1 Characteristics of participants with and without Down syndrome
Demographics Total (n = 32) Down syndrome (n = 16) Typically developing (n = 16) P d
Female, n (%) 15 (46.9) 6 (37.5) 9 (56.3) 0.29†
Age (years), M (SD) 14.8 (1.8) 14.7 (1.8) 14.9 (2.0) 0.83‡ 0.08
Tanner (III/IV/V), n 10/15/7 5/9/2 5/6/5 0.53†
Caucasian, n (%) 31 (96.9) 15 (93.8) 16 (100.0) 0.31†
Values are mean (standard deviation) or frequency (proportion) as noted. %, proportion of column sample; d, Cohen’s d effect size; n, frequency.
*P < 0.05.
†Pearson’s chi-square test (χ2).
‡Independent samples t-test (t).
Table 2 Differences in body composition between participants with and without Down syndrome
Body composition Total Down syndrome Typically developing P d
Weight (kg) 56.7 (13.5) 56.7 (10.3) 56.6 (16.4) 0.99‡ 0.01
Height (cm) 155.2 (13.1) 146.6 (8.2) 163.7 (11.4) <0.001‡* 1.31
BMI (kg/m2) 23.6 (5.0) 26.3 (4.1) 20.8 (4.2) 0.001‡* 1.12
BMI %ile 70.3 (28.5) 89.6 (11.0) 51.0 (27.7) <0.001‡* 1.35
Overweight/obese, n (%) 16 (50.0) 13 (81.2) 3 (18.8) <0.001†*
Body fat percentage 29.5 (9.8) 32.9 (10.8) 26.0 (7.5) 0.04‡* 0.70
Elevated BF, n (%) 13 (40.6) 10 (62.5) 3 (18.8) 0.01†*
Values are mean (standard deviation) unless otherwise noted. %, proportion of column sample; BMI, body mass index; BMI %ile, BMI percentile based on
Centers for Disease Control growth chart (Kuczmarski et al. 2000); d, Cohen’s d effect size; elevated BF, proportion of column sample with elevated body
fatness based on criteria outlined by Freedman et al. (2009); n, frequency; overweight/obese, proportion of column sample ≥ 85th %ile on CDC growth
chart.
*P < 0.05, bolded.
†Pearson’s chi-square test (χ
2
).
‡Independent samples t-test (t).
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P = 0.16) and in the slope across time (b = 0.06,
SE = 0.08, P = 0.43). The random intercept and
within-subject variance of repeated measures were
significant (P < 0.001), justifying the inclusion of
random effects in the model. Diurnal cortisol
trajectories across the day for adolescents with and
without Down syndrome are shown in Fig. 1.
To further examine the association between cortisol
and adiposity, model 2 analysed the interaction
between Down syndrome and elevated body fat
groupings (Table 4). In total, 13 adolescents exhibited
an elevated body fat percentage (40.62%), including
10 with Down syndrome (62.50%) and three with
typical development (18.75%). Once again, a
significant effect of hours since waking on log-cortisol
(b = 0.11, SE = 0.02, P < 0.001) was observed. The
main effects between disability groups (b = 0.18,
SE = 0.18, P = 0.34) and elevated fatness groups
(b = 0.12, SE = 0.19, P = 0.50) were not statistically
significant nor were any of the disability by adiposity
by time interactions. These relationships were
confirmed to be consistent across both adolescents
with Down syndrome and typical development in
models 2b and 2c. Diurnal cortisol patterns between
groups by Down syndrome and body fatness are
shown in Fig. 2. Planned post hoc pairwise
comparisons between disability and adiposity groups
at each time point were also not statistically significant
(P > 0.05). Adolescents with elevated fatness had
consistently higher cortisol levels, particularly in the
morning, but of only a small magnitude (d = 0.30).
Discussion
The current study examined whether diurnal cortisol
pattern was associated with the presence of Down
syndrome or degree of adiposity. To the best of our
knowledge, this is the first study to track diurnal
cortisol in adolescents with Down syndrome.
Previous studies in persons with Down syndrome
have examined cortisol in a single measure (Anneren
et al. 1986; Arnell et al. 1996; Hestnes et al. 1991;
Murdoch et al. 1979), during stress tests (Murdoch et
al. 1979) and during short periods of rest and exercise
(Bricout et al. 2008). Examining the diurnal cortisol
patterns through multiple measurements across the
day has provided more detailed information about
HPA axis activity and potential associations with
obesity.
A preliminary finding from this study is that
adolescents with Down syndrome do not appear to
Table 3 Linear mixed model of diurnal cortisol between adolescents
with and without Down syndrome (model 1)
Ln cortisol (μg/dL) Model 1†
Predictor b 95% CI P
Intercept 0.80 (1.18, 0.41) <0.001*
Fixed effects
Down syndrome (DS) REF
Typical development (TD) 0.23 (0.55, 0.09) 0.16
Hours 0.12 (0.16, 0.07) <0.001*
Time 0.11 (0.46, 0.25) 0.56
TD × Time 0.06 (0.10, 0.22) 0.43
Random effects
var (morning) 0.16 (0.11, 0.26) <0.001*
var (afternoon) 0.28 (0.19, 0.39) <0.001*
var (night) 0.52 (0.37, 0.71) <0.001*
Intercept 0.14 (0.08, 0.22) <0.001*
DS, Down syndrome; REF, reference group for categorical comparisons;
TD, typically developing.
*P < 0.05, bolded.
†Model 1: Schwarz’s Bayesian Criterion (BIC) = 585.74.
Figure 1. Diurnal cortisol pattern in adolescents with and without
Down syndrome (DS) (model 1). Cortisol (μg/dL) across time points.
Analyses are based on log-transformed cortisol. Post hoc linear
independent pairwise corrections with Bonferroni corrections based
on estimated marginal means controlling for hours since waking. (
*
)
Differences in cortisol between adolescents with Down syndrome and
typical development (TD), P < 0.05 (no differences observed).
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have different diurnal cortisol trajectories than
adolescents with typical development. A diurnal
pattern with high morning cortisol levels and a log-
linear decrease in concentration across the day was
observed for both groups, consistent with the
expected nature of this hormone (Pasquali et al.
2006). Cortisol levels were higher in adolescents with
Down syndrome at each time point compared with
adolescents with typical development. However,
neither the intercept (P = 0.16) nor the slope
(P = 0.43) was statistically different between the
groups. The lack of significant group differences is
consistent with studies utilising single measurements
of cortisol (Anneren et al. 1986; Hestnes et al. 1991;
Arnell et al. 1996; Murdoch et al. 1979). The observed
diurnal pattern, characterised by a significant negative
slope across hours (P < 0.001), confirms that
repeated measurements are required to properly
describe cortisol function. While Bricout et al. (2008)
found significantly lower cortisol levels during rest
and a blunted response to exercise among young
adult men with Down syndrome, it remains unclear
how these short periods of time fit into the diurnal
cortisol pattern. Absolute differences in cortisol
concentration between adolescents with Down
syndrome and typical development in the present
study, regardless of statistical significance, were larger
in the morning than at the other time points. The
significant differences observed by Bricout et al.
(2008) all occurred in the morning, but the time from
waking was not reported. Thus, the discrepancy in
cortisol patterns between the two studies may be
because of differences in the scope of measurement.
Furthermore, the current study was conducted in
adolescents while Bricout et al. (2008) examined
young adult men. This suggests that there may also be
systematic differences because of sex, age or pubertal
status (De Vriendt et al. 2009; Tsai et al. 2013),
despite the lack of a covariate effect within the current
study.
A second preliminary finding was that within both
adolescents with Down syndrome and typical
development, the presence of elevated adiposity was
not significantly associated with diurnal cortisol
Table 4 Linear mixed model of diurnal cortisol by Down syndrome and elevated fat mass (model 2)
Ln cortisol (μg/dL) Model 2a† total Model 2b‡ Down syndrome Model 2c§ typical development
Predictor b 95% CI P b 95% CI P b 95% CI P
Intercept 0.85 (1.30, 0.40) <0.001* 0.74 (1.23, 0.24) 0.004* 1.16 (1.71, 0.61) <0.001*
Fixed effects
Down syndrome (DS) REF – – – – – –
Typical development (TD) 0.18 (0.54, 0.18) 0.34 – – – – – –
Elevated BF% 0.12 (0.24, 0.49) 0.50 0.05 (0.35, 0.45) 0.793 0.21 (0.45, 0.88) 0.53
Hours 0.11 (0.16, 0.06) <0.001* 0.10 (0.16, 0.04) 0.002* 0.13 (0.21, 0.06) 0.001*
Time 0.09 (0.46, 0.27) 0.61 0.20 (0.65, 0.25) 0.382 0.06 (0.46, 0.58) 0.822
DS × Normal BF% × Time REF REF – – –
DS × Elevated BF% × Time 0.06 (0.26, 0.14) 0.58 0.02 (0.24, 0.19) 0.845 – – –
TD × Normal BF% × Time 0.02 (0.17, 0.22) 0.80 – – – REF
TD × Elevated BF% × Time 0.04 (0.26, 0.35) 0.77 – – – 0.02 (0.33, 0.28) 0.873
Random effects
var (morning) 0.17 (0.11, 0.26) <0.001* 0.08 (0.03, 0.19) 0.026* 0.26 (0.15, 0.45) <0.001*
var (afternoon) 0.28 (0.19, 0.40) <0.001* 0.21 (0.13, 0.36) <0.001* 0.35 (0.21, 0.57) <0.001*
var (night) 0.52 (0.38, 0.72) <0.001* 0.61 (0.39, 0.94) <0.001* 0.42 (0.26, 0.68) <0.001*
Intercept 0.14 (0.08, 0.22) <0.001* 0.14 (0.07, 0.25) 0.001* 0.13 (0.06, 0.29) 0.014*
BF%, body fat percentage; DS, Down syndrome; elevated BF, proportion of column sample with elevated body fatness based on criteria outlined by
Freedman et al. (2009); REF, reference group for categorical comparisons; TD, typical development.
*P < 0.05, bolded.
†Model 2a: Schwarz’s Bayesian Criterion (BIC) = 592.66.
‡Model 2b: BIC = 282.14.
§Model 2c: BIC = 320.11.
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trajectory. Previous studies in typically developing
children and adolescents have identified statistically
significant positive associations between cortisol
levels and BMI (Reinehr et al. 2014; Rosmalen et al.
2005; Veldhorst et al. 2014), visceral adipose tissue
(Misra et al. 2008), truncal fat mass (Barat et al. 2007;
Weigensberg et al., 2008) and waist circumference
(Guzzetti et al. 2014; Reinehr et al. 2014). Conversely,
statistically significant inverse relationships between
cortisol and BMI indices have also been reported
(Shirtcliff et al. 2012; Ruttle et al. 2013; Ondrak et al.
2011; Kjölhede et al. 2014). Additional researchers
have published non-significant findings of weak
positive (Hill et al. 2011; Syme et al. 2008), inverse
(Adam et al. 2010; Hill et al. 2010) or non-directional
associations (Rosmalen et al. 2005; Knutsson et al.
1997). Because of publication biases against non-
significant findings, it is possible that additional
examinations of cortisol and adiposity in children and
adolescents are not reflected in the published
literature.
A potential reason for these inconsistent
associations is the variety of research designs used to
examine this relationship. Across the studies
mentioned earlier, cortisol was measured through a
variety of mediums (e.g. saliva, blood serum, blood
plasma, urine and hair), sampling frequencies (e.g.
single measures and diurnal pattern) and time of day.
Body composition and adiposity were also measured
via BMI, total and segmental fat mass and waist
circumference. Finally, the age and pubertal status of
the adolescents and children studied vary widely
across studies. Taken together, it is difficult to
synthesise a clear correlation between cortisol
function and body composition in youth as
measurement, age, sex and pubertal status may all
influence this relationship. This point is best
represented by studies that found significant
associations in girls but not boys (Rosmalen et al.
2005) or in only overweight children but not normal
weight or obese children (Hill et al. 2011).
The adolescents with Down syndrome in the
present study reflect the common health issues of this
population, with over 80% of the sample categorised
as overweight or obese and over 60% categorised as
exhibiting elevated adiposity. These findings are
consistent with recent studies reporting BMI and
DXA data in adolescents with Down syndrome
(Bandini et al. 2012; Gonzalez-Aguero et al. 2011;
Loveday et al. 2012; Rimmer et al. 2010; Pitchford et
al. 2018), clearly demonstrating a health disparity
experienced by many individuals with Down
syndrome. Despite the high prevalence of excess
adiposity, co-morbid health conditions including
metabolic syndrome, type II diabetes and
hypertension are surprisingly absent in Down
syndrome (De Winter et al. 2012; Real de Asua et al.
2014; Draheim et al. 2002). The mechanism behind
this phenomenon is unclear, but sympathetic
hypoactivity and endocrine balances unique to Down
syndrome have been proposed (Corsi et al. 2009;
Adelekan et al. 2012; Agiovlasitis et al. 2010). Even
with the lack of metabolic and atherosclerotic
complications, obesity remains a serious health issue
for persons with Down syndrome because of
detrimental effects on mobility, independent living,
community participation and quality of life (Rimmer
& Yamaki 2006). Health promotion and direct
intervention efforts are clearly needed for this at-risk
population (Pitetti et al. 2013; Shields et al. 2009;
Rimmer et al. 2010). Study designs that allow
researchers to examine relationships between health
Figure 2. Association between diurnal cortisol and adiposity in
adolescents with and without Down syndrome (DS) (model 2).
Cortisol (μg/dL) across time points. Analyses are based on log-
transformed cortisol. Post hoc linear independent pairwise corrections
with Bonferroni corrections based on estimated marginal means
controlling for hours since waking. (
*
) Differences in cortisol between
adolescents with Down syndrome and typical development (TD),
P < 0.05 (no differences observed).
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behaviours and health conditions at baseline before
intervening to increase healthy behaviours may be
particularly beneficial.
Limitations
The current study has a number of limitations that are
important to consider when interpreting these results.
First, the current sample size is small and limits both
the statistical power and type of analyses that could be
conducted. As such, findings from this study should
be viewed as preliminary. The LMM procedures were
able to converge and were appropriate for the data
based on fit statistics. Interpretation of model 2,
however, is limited by the small number of
participants in each subgroup and may not be
generalisable. It is critical to re-examine these
research questions with a sample capable of
producing balanced subgroups. Furthermore, the
general pattern within each group was that cortisol
was lower among adolescents with normal body fat,
but, again, this was not significantly different. Given
this trend, the high prevalence of overweight in
adolescents with Down syndrome in the sample may
be affecting the ability to identify differences between
groups in model 1. The lack of significant differences
based on adiposity within adolescents with and
without Down syndrome could be because of the
small sample size of each group, the unbalanced
proportions of obesity across groups or are reflective
of an inconsistent associative relationship between
cortisol and adiposity. This potential confounder
should be specifically addressed in future studies.
Second, the current sample had a greater
proportion of overweight participants in the group
with Down syndrome. Analyses with equal
representation in BMI obesity status between groups
may alter results. However, matching groups for
obesity status, whether through BMI or body fat
(Gonzalez-Aguero et al. 2011), is only possible with a
leaner group of adolescents with Down syndrome and
a more overweight group of adolescents with typical
development. Such a sample would then have
questionable generalisability to either population. If
possible, future studies may attempt to recruit unique
equally distributed samples of adolescents with and
without Down syndrome as well as with and without
obesity to examine the independent and joint effects
of these factors.
Third, adolescents were excluded from the study if
they exhibited hormonal insufficiency, such as
hypothyroid, to remove any potential effect on the
HPA axis (Walter et al. 2012). Hypothyroidism is a
common condition among youth with Down
syndrome (Bull and Committee on Genetics 2011);
thus, the current sample and findings only represent
adolescents with Down syndrome with normal
thyroid function. Furthermore, through excluding
potential participants with hypothyroidism, we may
have also excluded the adolescents most likely to
exhibit elevated cortisol levels (Walter et al. 2012).
Despite these limitations, the current results provide
useful preliminary evidence to guide future research.
Conclusion
To our knowledge, this is the first study to describe
the diurnal pattern of cortisol in adolescents with
Down syndrome. An extensive body of evidence from
the general population supports the association
between cortisol dysfunction and obesity in adults
(Adam & Epel 2007; Bjorntorp & Rosmond 2000;
Pasquali et al. 2006; Rodriguez et al. 2015; Bjorntorp
2001; Bjorntorp 1996; Nieuwenhuizen & Rutters
2008); however, this relationship is highly variable in
adolescents and children (Reinehr et al. 2014; Misra et
al. 2008; Guzzetti et al. 2014; Weigensberg et al. 2008;
Barat et al. 2007; Veldhorst et al. 2014; Hill et al. 2011;
Rosmalen et al. 2005; Ruttle et al. 2013; Ondrak et al.
2011; Shirtcliff et al. 2012; Kjölhede et al. 2014). Our
preliminary findings suggest that diurnal cortisol
levels are not significantly different among
adolescents with Down syndrome compared with
typically developing peers; nor between adolescents
with elevated compared with normal levels of
adiposity. A larger study is warranted to better analyse
these relationships. Understanding the unique factors
that contribute to health disparities in obesity among
individuals with Down syndrome is a critical step in
efforts to design and implement health promotion
interventions.
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